Companies are racing to develop fast-acting depression drugs — but the process is tricky - STAT

STATCompanies are racing to develop fast-acting depression drugs — but the process is trickySTATs companies race to develop fast-acting antidepressants, they are grappling with how to design clinical trials for a type of drug that doesn't yet exist. There's no shortage of interest in the idea: Janssen (JNJ 1) is testing an esketamine nasal spray ...